Risk factors and psychological impact of syncope in migraine patients

Standard

Risk factors and psychological impact of syncope in migraine patients. / Kuan, Ai Seon; Chen, Shih-Pin; Wang, Yen-Feng; Fuh, Jong-Ling; Cheng, Chun-Yu; Peng, Kuan-Po; Wang, Shuu-Jiun.

In: CEPHALALGIA, Vol. 39, No. 14, 12.2019, p. 1838-1846.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Kuan, AS, Chen, S-P, Wang, Y-F, Fuh, J-L, Cheng, C-Y, Peng, K-P & Wang, S-J 2019, 'Risk factors and psychological impact of syncope in migraine patients', CEPHALALGIA, vol. 39, no. 14, pp. 1838-1846. https://doi.org/10.1177/0333102419865253

APA

Kuan, A. S., Chen, S-P., Wang, Y-F., Fuh, J-L., Cheng, C-Y., Peng, K-P., & Wang, S-J. (2019). Risk factors and psychological impact of syncope in migraine patients. CEPHALALGIA, 39(14), 1838-1846. https://doi.org/10.1177/0333102419865253

Vancouver

Bibtex

@article{32dc5eed81174bafbbf65da8ce1abd40,
title = "Risk factors and psychological impact of syncope in migraine patients",
abstract = "BACKGROUND: Migraine is associated with syncope. We investigated risk factors for syncope and burden of syncope in migraine patients.METHODS: Participants were recruited from a headache clinic. All participants provided information on lifestyle, co-morbidity, syncope, headache and suicide, and completed the MIDAS and HADS questionnaires. Genetic data were available for a subset of participants. Risk of syncope in relation to participant's characteristics and migraine susceptibility loci, and risks of psychological disorders associated with syncope, were calculated using logistic regression.RESULTS: Underweight, regular tea intake, diabetes mellitus, and migraine with aura were associated with increased syncope risks, with adjusted ORs of 1.76 (95% CI 1.03-3.03), 1.84 (95% CI 1.22-2.79), 4.70 (95% CI 1.58-13.95), and 1.78 (95% CI 1.03-3.10), respectively. Preliminary results showed that rs11172113 in LRP1 was associated with syncope risks. Comorbid syncope in migraine patients was associated with increased risks of depression (OR 1.95, 95% CI 1.18-3.22) and suicide attempt (OR 2.85, 95% CI 1.48-5.48).CONCLUSION: Our study showed the potential roles of vascular risk factors in the association between migraine and syncope. Modifiable risk factors for syncope in patients with migraine include body mass index and tea intake. The debilitating psychological impact of co-morbid syncope in migraine patients warrants clinical attention of treating physicians.",
author = "Kuan, {Ai Seon} and Shih-Pin Chen and Yen-Feng Wang and Jong-Ling Fuh and Chun-Yu Cheng and Kuan-Po Peng and Shuu-Jiun Wang",
year = "2019",
month = dec,
doi = "10.1177/0333102419865253",
language = "English",
volume = "39",
pages = "1838--1846",
journal = "CEPHALALGIA",
issn = "0333-1024",
publisher = "SAGE Publications",
number = "14",

}

RIS

TY - JOUR

T1 - Risk factors and psychological impact of syncope in migraine patients

AU - Kuan, Ai Seon

AU - Chen, Shih-Pin

AU - Wang, Yen-Feng

AU - Fuh, Jong-Ling

AU - Cheng, Chun-Yu

AU - Peng, Kuan-Po

AU - Wang, Shuu-Jiun

PY - 2019/12

Y1 - 2019/12

N2 - BACKGROUND: Migraine is associated with syncope. We investigated risk factors for syncope and burden of syncope in migraine patients.METHODS: Participants were recruited from a headache clinic. All participants provided information on lifestyle, co-morbidity, syncope, headache and suicide, and completed the MIDAS and HADS questionnaires. Genetic data were available for a subset of participants. Risk of syncope in relation to participant's characteristics and migraine susceptibility loci, and risks of psychological disorders associated with syncope, were calculated using logistic regression.RESULTS: Underweight, regular tea intake, diabetes mellitus, and migraine with aura were associated with increased syncope risks, with adjusted ORs of 1.76 (95% CI 1.03-3.03), 1.84 (95% CI 1.22-2.79), 4.70 (95% CI 1.58-13.95), and 1.78 (95% CI 1.03-3.10), respectively. Preliminary results showed that rs11172113 in LRP1 was associated with syncope risks. Comorbid syncope in migraine patients was associated with increased risks of depression (OR 1.95, 95% CI 1.18-3.22) and suicide attempt (OR 2.85, 95% CI 1.48-5.48).CONCLUSION: Our study showed the potential roles of vascular risk factors in the association between migraine and syncope. Modifiable risk factors for syncope in patients with migraine include body mass index and tea intake. The debilitating psychological impact of co-morbid syncope in migraine patients warrants clinical attention of treating physicians.

AB - BACKGROUND: Migraine is associated with syncope. We investigated risk factors for syncope and burden of syncope in migraine patients.METHODS: Participants were recruited from a headache clinic. All participants provided information on lifestyle, co-morbidity, syncope, headache and suicide, and completed the MIDAS and HADS questionnaires. Genetic data were available for a subset of participants. Risk of syncope in relation to participant's characteristics and migraine susceptibility loci, and risks of psychological disorders associated with syncope, were calculated using logistic regression.RESULTS: Underweight, regular tea intake, diabetes mellitus, and migraine with aura were associated with increased syncope risks, with adjusted ORs of 1.76 (95% CI 1.03-3.03), 1.84 (95% CI 1.22-2.79), 4.70 (95% CI 1.58-13.95), and 1.78 (95% CI 1.03-3.10), respectively. Preliminary results showed that rs11172113 in LRP1 was associated with syncope risks. Comorbid syncope in migraine patients was associated with increased risks of depression (OR 1.95, 95% CI 1.18-3.22) and suicide attempt (OR 2.85, 95% CI 1.48-5.48).CONCLUSION: Our study showed the potential roles of vascular risk factors in the association between migraine and syncope. Modifiable risk factors for syncope in patients with migraine include body mass index and tea intake. The debilitating psychological impact of co-morbid syncope in migraine patients warrants clinical attention of treating physicians.

U2 - 10.1177/0333102419865253

DO - 10.1177/0333102419865253

M3 - SCORING: Journal article

C2 - 31307206

VL - 39

SP - 1838

EP - 1846

JO - CEPHALALGIA

JF - CEPHALALGIA

SN - 0333-1024

IS - 14

ER -